Atlas Venture Fund XI, L.P. - 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Atlas Venture Fund XI, L.P. since 11 Mar 2025

Holdings reported by Atlas Venture Fund XI, L.P. for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,019,563 $1,292,520 $0.6400 08 Feb 2024 Direct
Common Stock 734,546 $470,109 $0.6400 08 Feb 2024 Indirect

Transactions reported by Atlas Venture Fund XI, L.P. for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.